Nimâ Machouf

1.6k total citations
50 papers, 1.1k citations indexed

About

Nimâ Machouf is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Nimâ Machouf has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Infectious Diseases, 26 papers in Virology and 15 papers in Epidemiology. Recurrent topics in Nimâ Machouf's work include HIV/AIDS Research and Interventions (38 papers), HIV Research and Treatment (26 papers) and HIV/AIDS drug development and treatment (25 papers). Nimâ Machouf is often cited by papers focused on HIV/AIDS Research and Interventions (38 papers), HIV Research and Treatment (26 papers) and HIV/AIDS drug development and treatment (25 papers). Nimâ Machouf collaborates with scholars based in Canada, United States and Burkina Faso. Nimâ Machouf's co-authors include Marina B. Klein, Curtis Cooper, Robert S. Hogg, Janet Raboud, Mona Loutfy, Pierre‐Edouard Fournier, Slim Haddad, Sean B. Rourke, Christos Tsoukas and Angela Cescon and has published in prestigious journals such as PLoS ONE, Social Science & Medicine and The Journal of Infectious Diseases.

In The Last Decade

Nimâ Machouf

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nimâ Machouf Canada	17	802	437	436	222	147	50	1.1k
Kenneth Tapia United States	23	857 1.1×	478 1.1×	495 1.1×	141 0.6×	235 1.6×	57	1.3k
Hermann Bussmann United States	23	951 1.2×	634 1.5×	465 1.1×	257 1.2×	143 1.0×	49	1.3k
John Idoko Nigeria	21	771 1.0×	260 0.6×	625 1.4×	140 0.6×	220 1.5×	78	1.3k
Nagalingeswaran Kumarasamy India	17	904 1.1×	350 0.8×	453 1.0×	140 0.6×	115 0.8×	49	1.2k
Pauli N. Amornkul United States	17	689 0.9×	363 0.8×	407 0.9×	107 0.5×	193 1.3×	24	1.1k
François Dabis France	16	949 1.2×	448 1.0×	490 1.1×	199 0.9×	280 1.9×	25	1.1k
Sanay Chearskul Thailand	16	1.1k 1.3×	527 1.2×	578 1.3×	209 0.9×	264 1.8×	42	1.3k
E. Bissagnené Ivory Coast	18	1.0k 1.3×	545 1.2×	491 1.1×	256 1.2×	103 0.7×	87	1.3k
Kimberly Struble United States	19	1.1k 1.4×	546 1.2×	555 1.3×	201 0.9×	108 0.7×	42	1.5k
James Hellinger United States	19	1.4k 1.7×	819 1.9×	741 1.7×	329 1.5×	216 1.5×	30	1.8k

Countries citing papers authored by Nimâ Machouf

Since Specialization

Citations

This map shows the geographic impact of Nimâ Machouf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nimâ Machouf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nimâ Machouf more than expected).

Fields of papers citing papers by Nimâ Machouf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nimâ Machouf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nimâ Machouf. The network helps show where Nimâ Machouf may publish in the future.

Co-authorship network of co-authors of Nimâ Machouf

This figure shows the co-authorship network connecting the top 25 collaborators of Nimâ Machouf. A scholar is included among the top collaborators of Nimâ Machouf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nimâ Machouf. Nimâ Machouf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loutfy, Mona, Curtis Cooper, Abigail Kroch, et al.. (2022). Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study. The Canadian Journal of Hospital Pharmacy. 75(4). 309–316. 1 indexed citations

Sereda, Paul, Erin Ding, Alex Wong, et al.. (2019). Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada. BMC Infectious Diseases. 19(1). 982–982. 9 indexed citations

Antoniou, Tony, Leah Szadkowski, Sharon Walmsley, et al.. (2017). Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients. BMC Infectious Diseases. 17(1). 266–266. 5 indexed citations

Cescon, Angela, Guillaume Colley, C. Kent Osborne, et al.. (2016). Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapy. HIV Medicine. 18(3). 151–160. 2 indexed citations

Trottier, Benoît, Danièle Longpré, Sylvie Vézina, et al.. (2014). Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: 96 weeks post VERITAS study. Journal of the International AIDS Society. 17(4S3). 19815–19815. 1 indexed citations

Cescon, Angela, Keith Chan, Janet Raboud, et al.. (2013). Significant differences in clinical outcomes between HIV-hepatitis C virus coinfected individuals with and without injection drug use history. AIDS. 28(1). 121–127. 14 indexed citations

Leung, Victor C. M., Jennifer Gillis, Janet Raboud, et al.. (2013). Predictors of CD4:CD8 Ratio Normalization and Its Effect on Health Outcomes in the Era of Combination Antiretroviral Therapy. PLoS ONE. 8(10). e77665–e77665. 57 indexed citations

Ndumbi, Patricia, Jennifer Gillis, Janet Raboud, et al.. (2013). Characteristics and determinants of T‐cell phenotype normalization in HIV‐1‐infected individuals receiving long‐term antiretroviral therapy. HIV Medicine. 15(3). 153–164. 7 indexed citations

Cescon, Angela, Sophie Patterson, Keith Chan, et al.. (2013). Gender Differences in Clinical Outcomes among HIV-Positive Individuals on Antiretroviral Therapy in Canada: A Multisite Cohort Study. PLoS ONE. 8(12). e83649–e83649. 40 indexed citations

10.

Antoniou, Tony, Jennifer Gillis, Mona Loutfy, et al.. (2013). Impact of the Data Collection on Adverse Events of Anti-HIV Drugs Cohort Study on Abacavir Prescription among Treatment-Naive, HIV-Infected Patients in Canada. Journal of the International Association of Providers of AIDS Care (JIAPAC). 13(2). 153–159. 6 indexed citations

11.

Raboud, Janet, Aranka Anema, DeSheng Su, et al.. (2012). Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy. HIV Clinical Trials. 13(2). 90–102. 5 indexed citations

12.

Loutfy, Mona, DeSheng Su, P. Richard Harrigan, et al.. (2012). Magnitude of Virologic Blips Is Associated With a Higher Risk for Virologic Rebound in HIV-Infected Individuals: A Recurrent Events Analysis. The Journal of Infectious Diseases. 205(8). 1230–1238. 92 indexed citations

13.

Tan, Darrell H. S., Keith Chan, Janet Raboud, et al.. (2011). Comparison of Abacavir/Lamivudine and Tenofovir/Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(1). 38–46. 15 indexed citations

14.

Loutfy, Mona, Miguel Genebat, David J. Moore, et al.. (2010). A CD4+ Cell Count <200 Cells per Cubic Millimeter at 2 Years After Initiation of Combination Antiretroviral Therapy Is Associated With Increased Mortality in HIV-Infected Individuals With Viral Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(4). 451–459. 39 indexed citations

15.

Palmer, Andy, Marina B. Klein, Janet Raboud, et al.. (2010). Cohort Profile: The Canadian Observational Cohort collaboration. International Journal of Epidemiology. 40(1). 25–32. 36 indexed citations

16.

Cooper, Curtis, K. Chan, Marina B. Klein, et al.. (2010). Factors associated with virological suppression among HIV-positive individuals on highly active antiretroviral therapy in a multi-site Canadian cohort. HIV Medicine. 12(6). 352–360. 51 indexed citations

17.

Raboud, Janet, Mona Loutfy, DeSheng Su, et al.. (2010). Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries. BMC Infectious Diseases. 10(1). 40–40. 17 indexed citations

18.

Machouf, Nimâ, Réjean Thomas, Vinh‐Kim Nguyen, et al.. (2006). Effects of drug resistance on viral load in patients failing antiretroviral therapy. Journal of Medical Virology. 78(5). 608–613. 28 indexed citations

19.

Routy, Jean‐Pierre, Nimâ Machouf, Michael Edwardes, et al.. (2004). Factors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in Montreal. AIDS. 18(17). 2305–2312. 31 indexed citations

20.

Haddad, Slim, et al.. (1998). What does quality mean to lay people? Community perceptions of primary health care services in Guinea. Social Science & Medicine. 47(3). 381–394. 131 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact